Gujarat Themis Biosyn Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 350.47 million compared to INR 271.98 million a year ago. Revenue was INR 357.61 million compared to INR 281.49 million a year ago. Net income was INR 137.92 million compared to INR 113.46 million a year ago. Basic earnings per share from continuing operations was INR 9.49 compared to INR 7.81 a year ago.
For the six months, sales was INR 674.87 million compared to INR 428.61 million a year ago. Revenue was INR 693.35 million compared to INR 446.72 million a year ago. Net income was INR 267.15 million compared to INR 169.19 million a year ago. Basic earnings per share from continuing operations was INR 18.39 compared to INR 11.65 a year ago.